Literature DB >> 7200244

Stereotyped behavior elicited by amphetamine in the rat: influences of the testes.

W W Beatty, A M Dodge, K L Traylor.   

Abstract

Castrating male rats in adulthood increased the duration of stereotyped behavior in responses of 5 mg/kg injections of d-amphetamine sulfate; exogenous treatment with testosterone propionate (TP) reversed this effect. Ovariectomy in adulthood had no effect on stereotypy, but TP injections reduced stereotyped responding by ovariectomized females. Thus testosterone exerts comparable effects on stereotypy elicited by amphetamine in both sexes. Males castrated at 1, 6 or 10 days of age but not males castrated in adulthood displayed levels of stereotyped behavior comparable to those of ovariectomized females when all animals were given TP in adulthood. Control experiments indicated that age of castration rather than time since castration was the critical factor, implying that secretions of the testes early in life exert effects on systems that regulate the responses of adults to amphetamine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7200244     DOI: 10.1016/0091-3057(82)90416-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  13 in total

Review 1.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Authors:  Dean Dluzen; Martin Horstink
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

2.  d-Amphetamine differentially affects low, but not high response rates of male and female Wistar rats.

Authors:  F van Haaren; R P Heinsbroek; A Louwerse; N E van de Poll
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion.

Authors:  Rebecca L Cunningham; Teresa Macheda; Lora Talley Watts; Ethan Poteet; Meharvan Singh; James L Roberts; Andrea Giuffrida
Journal:  Horm Behav       Date:  2011-08-31       Impact factor: 3.587

4.  Testosterone is essential for cocaine sensitization in male rats.

Authors:  Raissa Menéndez-Delmestre; Annabell C Segarra
Journal:  Physiol Behav       Date:  2010-10-14

5.  Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.

Authors:  Paola Devoto; Roberto Frau; Valentina Bini; Giuliano Pillolla; Pierluigi Saba; Giovanna Flore; Marta Corona; Francesco Marrosu; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2011-10-24       Impact factor: 4.905

6.  Androgen decreases dopamine neurone survival in rat midbrain.

Authors:  M L Johnson; A E Day; C C Ho; Q D Walker; R Francis; C M Kuhn
Journal:  J Neuroendocrinol       Date:  2010-01-27       Impact factor: 3.627

7.  Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats.

Authors:  Shayla E Russell; Anna B Rachlin; Karen L Smith; John Muschamp; Loren Berry; Zhiyang Zhao; Elena H Chartoff
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

8.  Gonadal steroids mediate the opposite changes in cocaine-induced locomotion across adolescence in male and female rats.

Authors:  Sarah L Parylak; Joseph M Caster; Q David Walker; Cynthia M Kuhn
Journal:  Pharmacol Biochem Behav       Date:  2008-01-16       Impact factor: 3.533

9.  Inhibition by amphetamine of testosterone secretion through a mechanism involving an increase of cyclic AMP production in rat testes.

Authors:  S C Tsai; Y C Chiao; C C Lu; M L Doong; Y H Chen; H C Shih; C Liaw; S W Wang; P S Wang
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

10.  Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra.

Authors:  Tertia D Purves-Tyson; David J Handelsman; Kay L Double; Samantha J Owens; Sonia Bustamante; Cynthia Shannon Weickert
Journal:  BMC Neurosci       Date:  2012-08-06       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.